Navigation Links
Vical Receives $6.3 Million Payment for Continued Funding of Allovectin-7(R) Phase 3 Trial
Date:6/12/2008

lomide, which has been approved by the FDA for the treatment of certain types of brain cancer but not for the treatment of metastatic melanoma. Temozolomide is an orally-delivered pro-drug that converts in the body into the same active compound as dacarbazine.

About Vical

Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Potential applications of the company's DNA delivery technology include DNA vaccines for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The company is developing certain infectious disease vaccines and cancer therapeutics internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product pipeline and address significant unmet medical needs. Additional information on Vical is available at http://www.vical.com.

This press release contains forward-looking statements subject to risks and uncertainties that could cause actual results to differ materially from those projected, including: whether Vical or others will continue development of Allovectin-7(R); whether Vical will be able to recruit patients into the AIMM trial as planned, if at all; whether Vical will receive all of the clinical trial funding from AnGes under the collaborative agreement, which will depend on continued development of Allovectin-7(R) and certain other conditions; whether Vical will receive any or all of the sales-based milestone payments and royalti
'/>"/>

SOURCE Vical Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders
2. Promise of Vicals CMV Vaccine Noted by Independent Experts
3. Study Finds QIAGENs HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap
4. Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial
5. Globus Medical Completes Enrollment Of SECURE(R)-C Cervical Artificial Disc Clinical Trial
6. Nventa Completes Safety Evaluation on Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
7. Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report
8. Vical Receives NIH Grant for an Immunotherapeutic Herpes DNA Vaccine; Herpes Experts at University of Washington and University of Texas to Conduct Preclinical Development
9. Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer
10. Nventa Announces Positive Interim Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial
11. Nventa Enrolls and Initiates Dosing of Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... HILL, N.C. , Jan. 23, 2015 For the ... are in dealing with payers. Likewise, the importance of the ... - will only continue to grow as payer formularies and ... access therapies. At the same time, managed markets ...
(Date:1/23/2015)... , Jan. 23, 2015 A lot of discussion ... methods for treating  certain illnesses, injuries, or conditions. As medical ... previous treatment methods with ones that they consider to be ... there is not one textbook method of treatment that stands ...
(Date:1/23/2015)... , Jan. 23, 2015  A new analysis of ... D 2015 enrollment data shows that 81 percent of ... access and extra discounts at certain pharmacies. The findings ... "Preferred pharmacy plans are now the foundation of Medicare ...
Breaking Medicine Technology:As Payer Influence Rises, Pharmaceutical Companies work to Optimize the Managed Markets Function 2No One-Size-Fits-All Remedy for Hernia Correction 2New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2
... 23 Select Medical Holdings Corporation ("Select") (NYSE: ... announced that it had received notice of the exercise ... 3,602,700 shares of Select,s common stock at a price ... on October 28, 2009, subject to customary closing conditions. ...
... NVAX ) a clinical-stage vaccine company, announced today that Fred ... Annual BIO Investor Forum 2009 at 11:00 am ... San Francisco, California. Mr. Driscoll will provide an overview of ... link to the live presentation can be accessed via the Company ...
Cached Medicine Technology:Select Medical Holdings Corporation Announces Exercise of Underwriters' Option to Purchase Additional Shares 2Novavax to Present at 8th Annual BIO Investor Forum 2009 2
(Date:1/22/2015)... New York (PRWEB) January 22, 2015 The ... ) in the U.S. District Court, Southern District of West ... Bard, Inc. in that proceeding’s first bellwether trial. In an ... for a new trial after finding that C.R. Bard had ...
(Date:1/22/2015)... January 22, 2015 For over 20 years, Dr. ... Oceanside and Vista area has treated just about every type ... injury circumstances. And for those same twenty-plus years, the team ... all those injuries with the best possible doctor. With ...
(Date:1/22/2015)... Weddingshe.com has added many trendy Champagne wedding dresses ... in the past three years. Today, the business announces a ... to the sales manager of the company, this is on ... This point can be reflected on the discounted wedding dresses ...
(Date:1/22/2015)... York, NY (PRWEB) January 22, 2015 As ... of overall health care gains momentum worldwide, Rev. Eric ... HealthCare Chaplaincy Network (HCCN), will be the keynote ... spiritual care in Israel’s public health system. , The conference, ...
(Date:1/22/2015)... January 22, 2015 State Forestry Institute ... management system with support from GEOSYSTEMS, a dedicated Hexagon ... solution will leverage Hexagon Geospatial’s ERDAS APOLLO ... as well as point clouds and documents. This effort ...
Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 3
... adults on Medicare reports drinking more alcohol than is ... , Even though alcohol problems are more prevalent ... are consuming alcohol in amounts that exceed recommended guidelines, ... Universitys Heller School for Social Policy and Management. The ...
... Year Revenue Up 47.3% and Net Income Up 63.5% ... Company Declares Cash Dividend of US$0.18 ... Mindray,Medical International Limited (NYSE: MR ), a leading ... a rapidly growing,international presence, today announced its selected unaudited ...
... infertility risks, experts say , , WEDNESDAY, March 5 ... targeted treatment than standard chemotherapy, the effective and much-touted ... women still in their reproductive years, imatinib (Gleevec) might ... future, according to a case report published as a ...
... WALNUT CREEK, Calif., March 5 Longs Drug,Stores ... income from,continuing operations for the fourth quarter ended ... or $1.00 per diluted share, including a,$1.1 million ... of seven,California stores. Income from continuing operations for ...
... MED ) announced today that it will release fourth quarter ... 2007 on,Wednesday, March 12, 2008 after the market closes. The ... results on Thursday, March 13,2008 at 11:00 a.m. ET., ... or,(201) 689-8567, or can listen via a live Internet web ...
... 2008 The American Cancer Society, the American College ... on Colorectal Cancer (a group that comprises representatives ... Association, and American Society for Gastrointestinal Endoscopy) have ... cancer screening. The guidelines add two new tests ...
Cached Medicine News:Health News:New study sheds light on excessive drinking among the elderly 2Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 2Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 3Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 4Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 5Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 6Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 7Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 8Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 9Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 10Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 11Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 12Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 13Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 14Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 15Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 16Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 17Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 18Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 19Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 20Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 21Health News:Gleevec May Disrupt Ovarian Function 2Health News:Gleevec May Disrupt Ovarian Function 3Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 2Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 3Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 4Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 5Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 6Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 7Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 8Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 9Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 10Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 11Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 12Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 13
Provides wrist stability with moderate motion restriction, making it ideal for the workplace...
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
... UNO Splint fits small, medium, and large - ... includes both dorsal and volar stays with D-ring ... those experiencing symptoms of Carpal Tunnel Syndrome, sprains ... - stock one splint to comfortably fit a ...
... brace is designed for the management ... The anatomically correct design achieves total ... optimal control of ulnar segments. Full ... is permitted to prevent problems associated ...
Medicine Products: